PLIANT THERAPEUTICS, INC. (PLRX) Free cash flow 2019–2025
PLIANT THERAPEUTICS, INC. (PLRX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$128.7MFY2025 · since FY2019: -$3.7M → -$128.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$128.7M | +19.2% |
| FY2024 | -$159.4M | -35.9% |
| FY2023 | -$117.3M | -21.7% |
| FY2022 | -$96.4M | -24.5% |
| FY2021 | -$77.4M | -99.5% |
| FY2020 | -$38.8M | -944.8% |
| FY2019 | -$3.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More PLRX financial trends
PLRX RevenuePLRX Net incomePLRX Net marginPLRX Gross profitPLRX Gross marginPLRX Operating incomePLRX Operating marginPLRX Operating cash flowPLRX Capital expendituresPLRX Return on equityPLRX Stock buybacksPLRX Dividends paidPLRX Total assetsPLRX Total liabilitiesPLRX Shareholders’ equityPLRX overview →